Continuous control of tracheal cuff pressure: an effective measure to prevent ventilator-associated pneumonia? by unknown
Rouzé et al. Critical Care 2014, 18:512
http://ccforum.com/content/18/4/512COMMENTARYContinuous control of tracheal cuff pressure: an
effective measure to prevent ventilator-associated
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Anahita Rouzé1, Emmanuelle Jaillette1 and Saad Nseir1,2*Abstract
In a previous issue of Critical Care, Lorente and
colleagues reported the results of a prospective
observational study aiming at evaluating the effect of
continuous control of cuff pressure (Pcuff ) on the
incidence of ventilator-associated pneumonia (VAP). The
results suggest a beneficial impact of this intervention
on VAP prevention, which is in line with the results of a
recent randomized controlled study. However,
another randomized controlled study found no
significant impact of continuous control of Pcuff on
VAP incidence. Several differences regarding the
device used to control Pcuff, study population, and
design might explain the different reported results.
Future randomized multicenter studies are needed to
confirm the beneficial effect of continuous control of
Pcuff on VAP incidence. Furthermore, the efficiency
and cost-effectiveness of different available devices
should be compared. Meanwhile, given the single-
center design and the limitations of the available
studies, no strong recommendation can be made
regarding continuous control of Pcuff as a preventive
measure of VAP.viously evaluated in critically ill patients.Introduction
In a previous issue of Critical Care, Lorente and col-
leagues [1] reported the results of a prospective study
aiming at evaluating the impact of continuous control
of cuff pressure (Pcuff ) on the incidence of ventilator-
associated pneumonia (VAP). They included a large
number of patients intubated and ventilated for more
than 48 hours (150 patients in a continuous control
group and 134 patients in a routine care group). The* Correspondence: s-nseir@chru-lille.fr
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org/publicdomain/zero/1.0) applies to the datatarget Pcuff was 25 cm H2O in both groups. Whereas
the main clinical characteristics were similar in the
study groups, VAP rate was significantly reduced by
the use of continuous control of Pcuff. Additionally,
continuous control of Pcuff and use of subglottic se-
cretion drainage were independently associated with
reduced incidence of VAP. Kaplan-Meier analysis showed
a significantly higher proportion of patients remaining free
from VAP using continuous control of Pcuff compared
with intermittent control using a manometer.Comparison with previous studies
The strengths of this study are the large number of in-
cluded patients and adjustment for confounders using
Cox proportional analysis. As acknowledged by the au-
thors, the absence of randomization and blinding is one
of the limitations of the study. In addition, the impact of
continuous control of Pcuff on tracheal ischemic lesions
was not evaluated. However, previous animal and clinical
studies found no significant effect of this intervention on
the incidence of intubation-related tracheal damage [2,3].
Furthermore, efficiency of the electronic device used by
the authors in continuously controlling Pcuff was not pre-
The lower rate of VAP in patients who received con-
tinuous control of Pcuff is in line with the results of a re-
cent randomized controlled study performed by our
group [4], although the primary outcome of that study
was not VAP but abundant microaspiration of gastric
content. Another randomized controlled study found no
significant impact of continuously controlling Pcuff on
VAP incidence [5]. Several differences regarding the de-
vice used to control Pcuff, study population, and design
might explain the different reported results (Table 1).td. The licensee has exclusive rights to distribute this article, in any medium, for 12
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Table 1 Characteristics of studies assessing the impact of

















Primary objective VAP Microaspiration VAP
Device Electronic Pneumatic Electronic
Target Pcuff, cm H2O 25 25 25










Semirecumbent position Yes Yes Yes
VAP incidence in control
group, %
15 26 22
Reduction in VAP rate,
%
NS 62 51
% Pcuff 20-30 cm H2O
in intervention group
79 98 100
CHX, chlorhexidine; NS, not significant; Pcuff, cuff pressure; VAP, ventilator-associated
pneumonia; X3/d, 3 times a day.
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Microaspiration of contaminated oropharyngeal and gas-
tric secretions is the main mechanism of entry of bacteria
into the lower respiratory tract [6]. Recently, several
markers of microaspiration, including pepsin and salivary
amylase, were described and validated [7-9]. Interestingly,
these markers are quantitative, allowing accurate evalu-
ation of microaspiration. It is well known that subsequent
development of VAP is tightly correlated to the quantity
of bacteria present in the lower respiratory tract [10]. The
use of these biomarkers in critically ill patients could be
helpful in evaluating the efficiency of a new device aiming
at reducing the incidence of VAP via the reduction of
microaspiration, before conducting large multicenter stud-
ies to test the effect of such a device on VAP incidence.
Underinflation of the tracheal cuff is usually defined as
Pcuff of less than 20 cm H2O and was identified by one
prospective observational study as an independent risk
factor for VAP in a subgroup of patients without antimi-
crobials [11]. However, microaspiration could occur at
higher Pcuff depending on tracheal anatomy and patient
movements [12]. In fact, microaspiration is a multifactorial
process related to mechanical ventilation, tracheal tube,
enteral nutrition, and general factors. Therefore, to pre-
vent microaspiration and subsequent VAP, all of these
factors, not just Pcuff, should be taken into account.Current practice and future studies
In spite of routine manual control of Pcuff using a man-
ometer, intubated critically ill patients spend a large
amount of time with underinflation and overinflation
(>30 cm H2O) of the tracheal cuff. In a cohort of 101
critically ill patients intubated with a polyvinylchloride-
cuffed tube, Pcuff was continuously recorded for 8 hours
after manual adjustment of Pcuff at 25 cm H2O [13].
Only 18 % of study patients spent 100 % of recording
time with a normal (20 to 30 cm H2O) Pcuff. Fifty-four
percent of study patients developed cuff underinflation,
73 % developed cuff overinflation, and 44 % developed
both. Subsequent studies reported similar results in
patients intubated with polyurethane-cuffed tracheal
tubes [14,15]. Several devices aiming at continuously
controlling Pcuff, including the one used by Lorente
and colleagues, are currently available on the market.
Unfortunately, the efficiency of some of these devices
was never tested in clinical studies. Therefore, before
these devices can be used in critically ill patients, well
designed and performed studies are required.
Conclusions
Future randomized multicenter studies should confirm the
beneficial effect of continuous control of Pcuff on VAP inci-
dence. Furthermore, the efficiency and cost-effectiveness of
different available devices should be compared. Meanwhile,
given the single-center design and the limitations of the
available studies, no strong recommendation can be
made regarding continuous control of Pcuff as a pre-
ventive measure of VAP.
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